Concepedia

Amy B. Hall

AB

6

Publications

872

Citations

6

H-Index

2002

Active since

Affiliations

Harvard University(Current)

Vertex Pharmaceuticals (United States)

State University of New York

Amy B. Hall is an author at Harvard University specializing in medicine, cell biology, and cell signaling.

Top concepts

Publications per year

2002–2016

6

Publications

6

Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970

Amy B. Hall, Dave Newsome, Yuxin Wang et al. · Oncotarget · 2014 · 189 citations · Full text

Requirements for Vav Guanine Nucleotide Exchange Factors and Rho GTPases in FcγR- and Complement-Mediated Phagocytosis

Amy B. Hall, M. Angelica Martinez Gakidis, Michael Glogauer et al. · Immunity · 2006 · 188 citations · Full text

, , +10

A paper-based invasion assay: Assessing chemotaxis of cancer cells in gradients of oxygen

Bobak Mosadegh, Matthew R. Lockett, Kyaw Thu Minn et al. · Biomaterials · 2015 · 142 citations · Full text

, , +14

The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins

James E. Egan, Amy B. Hall, Bogdan Yatsula et al. · Proceedings of the National Academy of Sciences · 2002 · 139 citations · Full text

, , +15

hSpry2 Is Targeted to the Ubiquitin-Dependent Proteasome Pathway by c-Cbl

Amy B. Hall, Natalia Jura, John O. DaSilva et al. · Current Biology · 2003 · 139 citations · Full text

, , +7

Rows per page

1–5 of 6